lightning reports™ from asco 2022: bladder cancer - episode 2
Published 2 years ago • 5 plays • Length 11:01Download video MP4
Download video MP3
Similar videos
-
13:13
lightning reports™ from asco 2022: bladder cancer - episode 1
-
9:28
lightning reports™ from asco 2022: targeted therapy in lung cancer - episode 2
-
10:27
lightning reports™ from asco 2022: targeted therapy in lung cancer - episode 1
-
15:51
conversations in high-risk non-muscle invasive bladder cancer
-
57:05
highlights in urologic oncology from asco 2022
-
56:38
second generation biolimus drug-coated balloon in clinical practice - europcr
-
36:09
bladder cancer 2022
-
19:11
theranostics: the future for prostate cancer treatment is here!!
-
8:27
urothelial carcinoma: ev-301 update from asco 2022
-
21:40
bladder cancer conference highlights from asco 2022
-
5:38
key data on bladder cancer from asco gu 2017
-
0:39
bladder cancer highlights at asco 2022
-
1:10
highlights in bladder cancer from asco 2022
-
5:32
key data on bladder cancer from asco gu 2017
-
4:45
highlights in kidney and bladder cancer at asco gu 2021
-
1:12
asco gu 2023: moving immunotherapy into the first-line setting for bladder cancer
-
32:19
asco updates 2020: bladder cancer with dr. manoj bupathi
-
2:22
bladder cancer advances | asco gu21
-
3:33
renal cancer update from asco 2023
-
0:46
uc highlights at asco 2022
-
2:40
‘it’s all about checkpoint inhibitors’ – rob jones on bladder cancer during asco 2017
-
1:57
bladder cancer research: multiplexed autoantibody profiling | dana-farber cancer institute